Increased risk of parkinsonism in women who underwent oophorectomy before menopause
暂无分享,去创建一个
L. Melton | D. Maraganore | M. de Andrade | W. Rocca | B. Grossardt | J. Ahlskog | J. Bower | L. J. Melton | M. D. Andrade
[1] L. Melton,et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause , 2007, Neurology.
[2] M. Broder,et al. Ovarian Conservation at the Time of Hysterectomy for Benign Disease , 2005, Obstetrics and gynecology.
[3] M. Broder,et al. Elective oophorectomy for benign gynecological disorders , 2007, Menopause.
[4] Tom Siegfried,et al. Neuroscience: It's all in the timing , 2007, Nature.
[5] Mariza de Andrade,et al. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. , 2006, The Lancet. Oncology.
[6] S. Khosla,et al. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.
[7] V. Henderson. The Neurology of Menopause , 2006, The neurologist.
[8] C. Tanner,et al. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease , 2005, Neurology.
[9] C. Farquhar,et al. The association of hysterectomy and menopause: a prospective cohort study , 2005, BJOG : an international journal of obstetrics and gynaecology.
[10] D. Schaid,et al. The Mayo Clinic Family Study of Parkinson’s Disease: Study Design, Instruments, and Sample Characteristics , 2005, Neuroepidemiology.
[11] D. Dexter,et al. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease , 2004, Pharmacology Biochemistry and Behavior.
[12] P. Aridon,et al. Risk of Parkinson disease in women , 2004, Neurology.
[13] G. Wooten,et al. Postmenopausal estrogen use affects risk for Parkinson disease. , 2004, Archives of neurology.
[14] D. Dluzen,et al. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system , 2003, Journal of Neural Transmission.
[15] F. Speizer,et al. Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease , 2003, Neurology.
[16] D. Dexter,et al. Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle , 2003, Neuroreport.
[17] Eun-Hee Ahn,et al. Effect of hysterectomy on conserved ovarian function. , 2001, Yonsei medical journal.
[18] D. Schaid,et al. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case‐control study , 2001, Movement disorders : official journal of the Movement Disorder Society.
[19] D. Dluzen,et al. Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system , 2001, Neuroscience.
[20] R. Roth,et al. Estrogen Is Essential for Maintaining Nigrostriatal Dopamine Neurons in Primates: Implications for Parkinson's Disease and Memory , 2000, The Journal of Neuroscience.
[21] T. Di Paolo,et al. Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice , 2000, Synapse.
[22] A. Gade,et al. Idiopathic selective amnesia with slow onset: A descriptive spect study , 2000, Neurobiology of Aging.
[23] R. Gibbs. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats☆ , 2000, Neurobiology of Aging.
[24] G. Cooper,et al. FSH levels in relation to hysterectomy and to unilateral oophorectomy. , 1999, Obstetrics and gynecology.
[25] A. Hofman,et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. , 1999, The Journal of clinical endocrinology and metabolism.
[26] D. Maraganore,et al. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.
[27] S. Fahn,et al. The effect of estrogen replacement on early Parkinson’s disease , 1999, Neurology.
[28] T. Spector,et al. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. , 1998, The Journal of clinical endocrinology and metabolism.
[29] D. Schaid,et al. Validation of a telephone questionnaire for Parkinson's disease. , 1998, Journal of clinical epidemiology.
[30] J. O'Callaghan,et al. The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity , 1998, Annals of the New York Academy of Sciences.
[31] K. Marder,et al. Postmenopausal estrogen use and Parkinson's disease with and without dementia , 1998, Neurology.
[32] D. Dluzen. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine , 1997, Brain Research.
[33] S. Dean. Hysterectomy and bone mineral density. , 1997, British journal of hospital medicine.
[34] L. Melton,et al. History of the Rochester Epidemiology Project. , 1996, Mayo Clinic proceedings.
[35] I. Bukovsky,et al. Ovarian function following abdominal hysterectomy with and without unilateral oophorectomy. , 1995, European journal of obstetrics, gynecology, and reproductive biology.
[36] W. O'Fallon,et al. Bilateral oophorectomy trends in Olmsted County, Minnesota, 1950-1987. , 1991, Epidemiology.